Related by context. Frequent words. (Click for all words.) 71 Initiates Phase II 70 R sorafenib tablets 70 PEG SN# 70 GVAX R 69 GRN#L 69 PLK1 SNALP 68 forodesine 68 Phase Ib II 68 phase IIb clinical 68 HGS ETR2 67 refractory chronic lymphocytic 67 SUCCEED trial 67 preclinical efficacy 67 BiTE R 67 AQ4N 66 ongoing Phase 1b 66 Presents Positive 66 Panzem R 66 RGB # 66 Initiate Phase 66 Factor VIIa 66 SAR# [004] 66 deforolimus 66 ThermoDox R 65 Trofex 65 sodium Injection 65 Receives Orphan Drug Designation 65 ALN TTR 65 Amrubicin 65 HGS ETR1 65 Pivotal Phase III 65 IMC #B 65 inflammatory autoimmune diseases 65 Thiarabine 65 liposomal formulation 64 TELINTRA 64 drug conjugate 64 GRNVAC1 64 phase IIa clinical 64 Inc. Nasdaq IMGN 64 multi kinase inhibitor 64 OXi# 64 vivo efficacy 64 subcutaneous formulation 63 multicenter Phase 63 RH1 63 ALN VSP 63 JAK1 63 JAK inhibitor 63 INCB# [001] 63 Phase 2a clinical 63 NASDAQ LGND 63 Inc. Nasdaq SUPG 63 Nasdaq ALTH 63 PEGPH# 63 DNA RNA Medicines 63 MEK inhibitor 63 MOZOBIL 63 Phase Ib clinical 63 Commences Phase 63 Initiates Phase 63 www.vivus.com 63 Pharmion Corporation 63 Nasdaq ENZN 63 developing Zerenex TM 63 CR# vcMMAE 63 Daclizumab 63 CORT # 62 NASDAQ OSIR 62 Therapeutic Competitors 62 Pivotal Phase 62 dacetuzumab 62 Soliris TM eculizumab 62 anticancer compound 62 Completes Enrollment 62 phase Ib 62 HCV protease inhibitor 62 ALN TTR# 62 TELCYTA 62 www.allos.com 62 Locteron ® 62 proteasome inhibitor 62 squalamine 62 Preclinical Data 62 kinase inhibitor 62 Nasdaq ENMD 62 Genasense R oblimersen 62 angiogenesis inhibitor 62 Inc. Nasdaq VVUS 62 Entereg R 61 vosaroxin 61 PXD# 61 pertuzumab 61 elotuzumab 61 Phase 2b clinical trials 61 vascular disrupting agent 61 eniluracil 61 NS5A 61 Cotara R 61 Nasdaq REGN 61 Meets Primary Endpoint